It upregulates hypoxia-inducible factor 1 α (HIF-1α) and Vascular Endothelial Growth Factor (VEGF) in human lung cancer cells (including A549), and many of these effects are mediated by α7-nAChR [5,20,21]. This evidence concerns the gene CHRNA7 and lung cancer.